The Patent Finder

Epic Sciences, Inc.

3 patents currently held · Updated Nov 15, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

1
Ending by 2030
Jan 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Jul 7 to 28, 2027 · next Jul 7

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 3 of 3

PatentTitleStatus Expires Confidence
US 10,613,089Method of Using Non-Rare Cells to Detect Rare Cells
In force
 · Medium confidence
In forceMedium confidence
US 10,527,624Circulating Tumor Cell Diagnostics for Prostate Cancer Biomarkers
In force
 · High confidence
In forceHigh confidence
US 10,545,151Methods for Analyzing Rare Circulating Cells
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 3: 2 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending · 16 abandoned · 14 no status recorded

Showing 1 to 10 of 33, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/770,366Single Cell Genomic Profiling of Circulating Tumor Cells (CTCS) in Metastatic Disease to Characterize Disease HeterogeneityJul 11, 2024Pending
18/746,816Methods of Determining Therapies Based on Single Cell Characterization of Circulating Tumor Cells (CTCS) in Metastatic DiseaseJun 18, 2024Pending
18/676,257Methods for the Detection and Quantification of Circulating Tumor Cell MimicsMay 28, 2024Pending
18/495,585Oct 26, 2023No status recorded
18/308,579Apr 27, 2023No status recorded
18/175,427Feb 27, 2023No status recorded
18/076,945Enhanced Characterization of Breast CancerDec 7, 2022Abandoned
17/746,756Method of Using Non-Rare Cells to Detect Rare CellsMay 17, 2022Abandoned
17/700,146Mar 21, 2022No status recorded
17/579,437Jan 19, 2022No status recorded
10 of 33 applications shown.
Pro members see all 33 published applications.
Pro members: see all 33 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited